Dr. Bartley P. Griffith, a 30 year old lung disease specialist and faculty member at the University of Maryland School of Medicine founded Breethe in 2014. The company is developing a portable artifician lung that can let patients continue their treatment away from the hospital. They just announced that they have finalized an agreement with UM Ventures, the university’s commercialization office, to license their technology.
The device works like a lung, circulating air and blood. The device is wearable and is small enough to put into a backpack. As Griffith explained,
“Our respiratory assist and cardiopulmonary support technology has the potential to dramatically improve patient care and quality of life by enabling otherwise hospital-bound patients to leave the hospital and resume more of their daily activities.”